Literature DB >> 20631685

Dopamine transporter (SLC6A3) genotype impacts neurophysiological correlates of cognitive response control in an adult sample of patients with ADHD.

Thomas Dresler1, Ann-Christine Ehlis, Sebastian Heinzel, Tobias J Renner, Andreas Reif, Christina G Baehne, Monika Heine, Andrea Boreatti-Hümmer, Christian P Jacob, Klaus-Peter Lesch, Andreas J Fallgatter.   

Abstract

Studies provide ample evidence for a dysfunction in dopaminergic neurotransmission in Attention-Deficit/Hyperactivity Disorder (ADHD). In that respect, a common variable number of tandem repeats (VNTR) polymorphism in the 3' untranslated region (UTR) of the dopamine transporter gene (SLC6A3) has been repeatedly associated with the disorder. Here, we examined the influence of the common 9- and 10-repeat alleles of SLC6A3 on prefrontal brain functioning and cognitive response control in a large sample of adult ADHD patients (n=161) and healthy controls (n=109). To this end, we inspected a neurophysiological marker of cognitive response control (NoGo anteriorization, NGA) elicited by means of a Go-NoGo task (continuous performance test, CPT). Within the group of ADHD patients, nine-repeat allele carriers showed significantly reduced NGA, whereas no influence of SLC6A3 genotype was observed in the control group. In contrast to previous association studies of children, the nine-repeat-not the 10-repeat-allele was associated with functional impairments in our sample of adult ADHD patients. Our findings confirm a significant effect of the SLC6A3 genotype on the neurophysiological correlates of cognitive response control in ADHD, and indicate that still to-be-identified age-related factors are important variables modulating the effect of genetic factors on endophenotypes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20631685      PMCID: PMC3055310          DOI: 10.1038/npp.2010.91

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  64 in total

Review 1.  Functional imaging with low-resolution brain electromagnetic tomography (LORETA): a review.

Authors:  R D Pascual-Marqui; M Esslen; K Kochi; D Lehmann
Journal:  Methods Find Exp Clin Pharmacol       Date:  2002

2.  The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression.

Authors:  S Fuke; S Suo; N Takahashi; H Koike; N Sasagawa; S Ishiura
Journal:  Pharmacogenomics J       Date:  2001       Impact factor: 3.550

3.  Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: a study with functional MRI.

Authors:  K Rubia; S Overmeyer; E Taylor; M Brammer; S C Williams; A Simmons; E T Bullmore
Journal:  Am J Psychiatry       Date:  1999-06       Impact factor: 18.112

4.  Expression of the dopamine transporter gene is regulated by the 3' UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR.

Authors:  Jonathan Mill; Philip Asherson; Clare Browes; Ursula D'Souza; Ian Craig
Journal:  Am J Med Genet       Date:  2002-12-08

Review 5.  Psychological heterogeneity in AD/HD--a dual pathway model of behaviour and cognition.

Authors:  Edmund J S Sonuga-Barke
Journal:  Behav Brain Res       Date:  2002-03-10       Impact factor: 3.332

6.  Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia.

Authors:  M F Egan; T E Goldberg; B S Kolachana; J H Callicott; C M Mazzanti; R E Straub; D Goldman; D R Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

Review 7.  Attention-deficit hyperactivity disorder.

Authors:  Joseph Biederman; Stephen V Faraone
Journal:  Lancet       Date:  2005 Jul 16-22       Impact factor: 79.321

8.  Tph2 gene variants modulate response control processes in adult ADHD patients and healthy individuals.

Authors:  C G Baehne; A-C Ehlis; M M Plichta; A Conzelmann; P Pauli; C Jacob; L Gutknecht; K-P Lesch; A J Fallgatter
Journal:  Mol Psychiatry       Date:  2008-04-22       Impact factor: 15.992

Review 9.  Validating psychiatric endophenotypes: inhibitory control and attention deficit hyperactivity disorder.

Authors:  Jennifer Crosbie; Daniel Pérusse; Cathy L Barr; Russell J Schachar
Journal:  Neurosci Biobehav Rev       Date:  2007-05-18       Impact factor: 8.989

Review 10.  Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis.

Authors:  Viktória Simon; Pál Czobor; Sára Bálint; Agnes Mészáros; István Bitter
Journal:  Br J Psychiatry       Date:  2009-03       Impact factor: 9.319

View more
  18 in total

Review 1.  Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder.

Authors:  Marc A Mergy; Raajaram Gowrishankar; Gwynne L Davis; Tammy N Jessen; Jane Wright; Gregg D Stanwood; Maureen K Hahn; Randy D Blakely
Journal:  Neurochem Int       Date:  2013-12-08       Impact factor: 3.921

Review 2.  Past, present, and future of genetic research in borderline personality disorder.

Authors:  Anahita Bassir Nia; Matthew C Eveleth; Jonathan M Gabbay; Yonis J Hassan; Bosi Zhang; M Mercedes Perez-Rodriguez
Journal:  Curr Opin Psychol       Date:  2017-09-12

3.  Epigenetics in Developmental Disorder: ADHD and Endophenotypes.

Authors:  Trevor Archer; Marlene Oscar-Berman; Kenneth Blum
Journal:  J Genet Syndr Gene Ther       Date:  2011-06-30

4.  Influence of a latrophilin 3 (LPHN3) risk haplotype on event-related potential measures of cognitive response control in attention-deficit hyperactivity disorder (ADHD).

Authors:  Andreas J Fallgatter; Ann-Christine Ehlis; Thomas Dresler; Andreas Reif; Christian P Jacob; Mauricio Arcos-Burgos; Maximilian Muenke; Klaus-Peter Lesch
Journal:  Eur Neuropsychopharmacol       Date:  2012-12-12       Impact factor: 4.600

5.  Functional Impact of An ADHD-Associated DIRAS2 Promoter Polymorphism.

Authors:  Lena Grünewald; Elisabeth Toverud Landaas; Julia Geissler; Heike Weber; Carina Quast; Simone Röh; Christoph Schartner; Klaus-Peter Lesch; Marcel Romanos; Sarah Kittel-Schneider; Elisabeth Binder; Andreas Reif
Journal:  Neuropsychopharmacology       Date:  2016-07-01       Impact factor: 7.853

Review 6.  Electrophysiological markers of genetic risk for attention deficit hyperactivity disorder.

Authors:  Charlotte Tye; Gráinne McLoughlin; Jonna Kuntsi; Philip Asherson
Journal:  Expert Rev Mol Med       Date:  2011-03-23       Impact factor: 5.600

Review 7.  The genetics of attention deficit/hyperactivity disorder in adults, a review.

Authors:  B Franke; S V Faraone; P Asherson; J Buitelaar; C H D Bau; J A Ramos-Quiroga; E Mick; E H Grevet; S Johansson; J Haavik; K-P Lesch; B Cormand; A Reif
Journal:  Mol Psychiatry       Date:  2011-11-22       Impact factor: 15.992

8.  Dopamine transporter (DAT1) and dopamine receptor D4 (DRD4) genotypes differentially impact on electrophysiological correlates of error processing.

Authors:  Stefanie C Biehl; Thomas Dresler; Andreas Reif; Peter Scheuerpflug; Jürgen Deckert; Martin J Herrmann
Journal:  PLoS One       Date:  2011-12-05       Impact factor: 3.240

Review 9.  Imaging genetics in adult attention-deficit/hyperactivity disorder (ADHD): a way towards pathophysiological understanding?

Authors:  Thomas Dresler; Beatrix Barth; Thomas Ethofer; Klaus-Peter Lesch; Ann-Christine Ehlis; Andreas J Fallgatter
Journal:  Borderline Personal Disord Emot Dysregul       Date:  2014-05-12

10.  Neurofeedback as a nonpharmacological treatment for adults with attention-deficit/hyperactivity disorder (ADHD): study protocol for a randomized controlled trial.

Authors:  Kerstin Mayer; Sarah Nicole Wyckoff; Andreas J Fallgatter; Ann-Christine Ehlis; Ute Strehl
Journal:  Trials       Date:  2015-04-18       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.